205 related articles for article (PubMed ID: 20950342)
1. Transient receptor potential ankyrin 1: emerging pharmacology and indications for cardiovascular biology.
Bodkin JV; Brain SD
Acta Physiol (Oxf); 2011 Sep; 203(1):87-98. PubMed ID: 20950342
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the biology and medicinal chemistry of TRPA1.
Rech JC; Eckert WA; Maher MP; Banke T; Bhattacharya A; Wickenden AD
Future Med Chem; 2010 May; 2(5):843-58. PubMed ID: 21426205
[TBL] [Abstract][Full Text] [Related]
3. TRPA1 modulators in preclinical development.
Viana F; Ferrer-Montiel A
Expert Opin Ther Pat; 2009 Dec; 19(12):1787-99. PubMed ID: 19939193
[TBL] [Abstract][Full Text] [Related]
4. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
Niforatos W; Zhang XF; Lake MR; Walter KA; Neelands T; Holzman TF; Scott VE; Faltynek CR; Moreland RB; Chen J
Mol Pharmacol; 2007 May; 71(5):1209-16. PubMed ID: 17314320
[TBL] [Abstract][Full Text] [Related]
5. TRPA1 antagonists as potential analgesic drugs.
Andrade EL; Meotti FC; Calixto JB
Pharmacol Ther; 2012 Feb; 133(2):189-204. PubMed ID: 22119554
[TBL] [Abstract][Full Text] [Related]
6. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons.
Anand U; Otto WR; Facer P; Zebda N; Selmer I; Gunthorpe MJ; Chessell IP; Sinisi M; Birch R; Anand P
Neurosci Lett; 2008 Jun; 438(2):221-7. PubMed ID: 18456404
[TBL] [Abstract][Full Text] [Related]
7. Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells.
Louhivuori LM; Bart G; Larsson KP; Louhivuori V; Näsman J; Nordström T; Koivisto AP; Akerman KE
J Cell Physiol; 2009 Oct; 221(1):67-74. PubMed ID: 19507192
[TBL] [Abstract][Full Text] [Related]
8. TRPA1 expression in human lingual nerve neuromas in patients with and without symptoms of dysaesthesia.
Morgan CR; Bird EV; Robinson PP; Boissonade FM
Neurosci Lett; 2009 Nov; 465(2):189-93. PubMed ID: 19715741
[TBL] [Abstract][Full Text] [Related]
9. Enhanced activation of the transient receptor potential channel TRPA1 by ajoene, an allicin derivative.
Yassaka RT; Inagaki H; Fujino T; Nakatani K; Kubo T
Neurosci Res; 2010 Jan; 66(1):99-105. PubMed ID: 19808063
[TBL] [Abstract][Full Text] [Related]
10. Caffeine activates mouse TRPA1 channels but suppresses human TRPA1 channels.
Nagatomo K; Kubo Y
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17373-8. PubMed ID: 18988737
[TBL] [Abstract][Full Text] [Related]
11. TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD.
Stokes A; Wakano C; Koblan-Huberson M; Adra CN; Fleig A; Turner H
Cell Signal; 2006 Oct; 18(10):1584-94. PubMed ID: 16500080
[TBL] [Abstract][Full Text] [Related]
12. NPPB structure-specifically activates TRPA1 channels.
Liu K; Samuel M; Ho M; Harrison RK; Paslay JW
Biochem Pharmacol; 2010 Jul; 80(1):113-21. PubMed ID: 20226176
[TBL] [Abstract][Full Text] [Related]
13. The dilated TRPA1 channel pore state is blocked by amiloride and analogues.
Banke TG
Brain Res; 2011 Mar; 1381():21-30. PubMed ID: 21241666
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet light and photosensitising agents activate TRPA1 via generation of oxidative stress.
Hill K; Schaefer M
Cell Calcium; 2009 Feb; 45(2):155-64. PubMed ID: 18814910
[TBL] [Abstract][Full Text] [Related]
15. A role for transient receptor potential ankyrin 1 cation channel (TRPA1) in airway hyper-responsiveness?
Jha A; Sharma P; Anaparti V; Ryu MH; Halayko AJ
Can J Physiol Pharmacol; 2015 Mar; 93(3):171-6. PubMed ID: 25654580
[TBL] [Abstract][Full Text] [Related]
16. Sustained TRPA1 activation in vivo.
Koivisto A
Acta Physiol (Oxf); 2012 Feb; 204(2):248-54. PubMed ID: 21518269
[TBL] [Abstract][Full Text] [Related]
17. 2-Amino-4-arylthiazole compounds as TRPA1 antagonists (WO 2012085662): a patent evaluation.
De Petrocellis L; Schiano Moriello A
Expert Opin Ther Pat; 2013 Jan; 23(1):119-47. PubMed ID: 23126422
[TBL] [Abstract][Full Text] [Related]
18. Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists.
Chen J; Lake MR; Sabet RS; Niforatos W; Pratt SD; Cassar SC; Xu J; Gopalakrishnan S; Pereda-Lopez A; Gopalakrishnan M; Holzman TF; Moreland RB; Walter KA; Faltynek CR; Warrior U; Scott VE
J Biomol Screen; 2007 Feb; 12(1):61-9. PubMed ID: 17099245
[TBL] [Abstract][Full Text] [Related]
19. Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
Gijsen HJ; Berthelot D; Zaja M; Brône B; Geuens I; Mercken M
J Med Chem; 2010 Oct; 53(19):7011-20. PubMed ID: 20806939
[TBL] [Abstract][Full Text] [Related]
20. Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor.
Defalco J; Steiger D; Gustafson A; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2010 Jan; 20(1):276-9. PubMed ID: 19945872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
